ScotusCrim is a recurring series by Rory Little focusing on intersections between the Supreme Court and criminal law. A lot has happened on the Supreme Court’s docket since my September […] The post A ...
On December 22, 2025, Novo Nordisk announced that the U.S. Food and Drug Administration approved its 25 mg oral Wegovy weight-loss pill—the first FDA-approved oral GLP-1 therapy for chronic weight ...
Clay Halton was a Business Editor at Investopedia and has been working in the finance publishing field for more than five years. He also writes and edits personal finance content, with a focus on ...
SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and ...
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well ...
VC Versant Ventures is unveiling Dayra Therapeutics, a new biotech working on oral macrocyclic peptide drugs—a mission that has already reeled in a partnership with Biogen. The biopharma has paid $50 ...
An update from Computershare Limited ( (AU:CPU)) is now available. Computershare Limited has released the presentations for its 2025 Annual General Meeting, which will be delivered by Chairman Paul ...
Qubits, unlike classical bits, can exist as both 0 and 1 simultaneously, enabling vast data storage. Quantum computers work fast to solve complex problems, significantly outpacing traditional ...
Oral Presentation during the emerging targets session on CLY-124, a clinical stage, first-in-class DCN1 inhibitor designed for sickle cell disease Second oral presentation during the novel ...
Prof. Matthew Montebello realised something was wrong when a group of students submitted a written assignment that made no logical sense. The third section contradicted the second, and none of the ...
PRINCETON, N.J., Oct. 16, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. ("ANI” or the "Company”) (Nasdaq: ANIP) today announced that results from the NEW DAY clinical trial of ILUVIEN® ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results